New test touted for Hepatitis C victims

Apr 27, 2006

Rockville, Md.-based Celera Genomics said Wednesday it has developed a genetic test to help determine which Hepatitis C sufferers are at greatest risk.

The test that focuses on seven genes is intended to predict which of the nearly 4 million U.S. residents with Hepatitis C are most likely to develop cirrhosis or cancer, and those that can avoid the estimated $30,000 annual cost to take drug cocktails.

"The current therapies to treat hepatitis C are fairly noxious," Dr. Scott Friedman of Mount Sinai School of Medicine told The New York Times.

"One of the tough decisions we face as clinicians is who should be treated with current antiviral therapies and who can afford to wait," said Friedman, who collaborated with Celera in devising the genetic test.

Celera President Kathy Ordonez said the company hopes to license the test to a laboratory by the end of the year.

Celera planned to introduce its test Friday to a Vienna meeting of the European Association for the Study of the Liver.

Copyright 2006 by United Press International

Explore further: And now the Acropolis is crumbling...

add to favorites email to friend print save as pdf

Related Stories

SlipChip counts molecules with chemistry and a cell phone

Nov 18, 2013

(Phys.org) —In developing nations, rural areas, and even one's own home, limited access to expensive equipment and trained medical professionals can impede the diagnosis and treatment of disease. Many qualitative ...

'Nanorobot' can be programmed to target different diseases

Jul 16, 2012

(Phys.org) -- University of Florida researchers have moved a step closer to treating diseases on a cellular level by creating a tiny particle that can be programmed to shut down the genetic production line that cranks out ...

FDA panel endorses Vertex hepatitis C drug

Apr 28, 2011

(AP) -- Federal health experts say an experimental hepatitis C drug from Vertex Pharmaceuticals Inc. is a significant step forward in treating the virus, despite a high rate of rashes among patients taking the tablet.

Recommended for you

And now the Acropolis is crumbling...

2 hours ago

Just when Greece thought it had come through the worst of the crisis it was hit by a new blow Wednesday—the Acropolis is crumbling.

Power can corrupt even the honest

9 hours ago

When appointing a new leader, selectors base their choice on several factors and typically look for leaders with desirable characteristics such as honesty and trustworthiness. However once leaders are in power, can we trust ...

Learning at 10 degrees north

9 hours ago

Secluded beaches, calypso music and the entertaining carnival are often what come to mind when thinking of the islands of Trinidad and Tobago. But Dal Earth Sciences students might first consider Trinidad's ...

How to find the knowns and unknowns in any research

11 hours ago

Have you ever felt overloaded by information? Ever wondered how to make sense of claims and counter-claims about a topic? With so much information out there on many different issues, how is a person new to ...

User comments : 0